Expect to Dispense a Formulary Alternative Instead of the New COPD Med, Yupelri

April 2019

Yupelri (yoo-PEL-ree) will be a new nebulized med for COPD.

Think of Yupelri (revefenacin) as an alternative to Lonhala Magnair (glycopyrrolate). They're both long-acting "anticholinergics" given via a nebulizer.

But there are a few differences that will give Yupelri an edge.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Automated Dispensing Use the Latest Safety Strategies for Automated Dispensing Cabinets
Medication Errors Help Catch Duplicate Therapy Errors
Measles Be Prepared if a Measles Outbreak Brings Patients to Your Hospital
Infectious Diseases Anticipate More Orders for Colistin and Polymyxin B
Hyperkalemia Think of Lokelma as Similar to Kayexalate or Veltassa for High Potassium
Anticoagulants Don't Be Surprised to See DOACs for Heparin-Induced Thrombocytopenia
Nitrates Prevent Mix-Ups With Sublingual Nitroglycerin
Ulcerative Colitis Know How Meds for Ulcerative Colitis Stack Up
COPD Expect to Dispense a Formulary Alternative Instead of the New COPD Med, Yupelri
Anxiety Stay Alert for Common Errors With Anxiety Meds

Expect to Dispense a Formulary Alternative Instead of the New COPD Med, Yupelri

Practical advice for a better career, with unlimited access to CE

Table of Contents